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Research
Whole genome sequencing of multiple Leishmania
donovani clinical isolates provides insights
into population structure and mechanisms
of drug resistance
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Visceral leishmaniasis is a potentially fatal disease endemic to large parts of Asia and Africa, primarily caused by the
protozoan parasite Leishmania donovani. Here, we report a high-quality reference genome sequence for a strain of L. donovani
from Nepal, and use this sequence to study variation in a set of 16 related clinical lines, isolated from visceral leishmaniasis
patients from the same region, which also differ in their response to in vitro drug susceptibility. We show that whole-
genome sequence data reveals genetic structure within these lines not shown by multilocus typing, and suggests that drug
resistance has emerged multiple times in this closely related set of lines. Sequence comparisons with other Leishmania species
and analysis of single-nucleotide diversity within our sample showed evidence of selection acting in a range of surface- and
transport-related genes, including genes associated with drug resistance. Against a background of relative genetic ho-
mogeneity, we found extensive variation in chromosome copy number between our lines. Other forms of structural
variation were significantly associated with drug resistance, notably including gene dosage and the copy number of an
experimentally verified circular episome present in all lines and described here for the first time. This study provides a basis
for more powerful molecular profiling of visceral leishmaniasis, providing additional power to track the drug resistance
and epidemiology of an important human pathogen.
[Supplemental material is available for this article.]
Leishmaniases are a complex of diseases that range from self-cur-
ing lesions to gross disfigurations and potentially deadly visceral
disease. The diseases are caused by protozoan parasites that are
transmitted by sandflies in 88 countries and infect an estimated 12
million people (www.who.int/leishmaniasis/en/). Parasites of the
Leishmania genus are remarkably biologically, clinically, and epi-
demiologically diverse and present enormous differences in dis-
ease tropism. The mildest form is cutaneous leishmaniasis, which
is caused by Leishmania major and other species, and is largely
limited to lesions around the area of a sandfly bite—though a dif-
fuse form can also occur. Disfiguring mucocutaneous leishmania-
sis is due to the destruction of nasopharyngeal tissue by parasites
such as L. braziliensis. More significantly, visceral leishmaniasis is
caused by parasites of the L. donovani species complex that can
spread to internal organs and cause death.
In 2005, sequencing the genome of L. major identified 8311
protein-coding genes and provided a framework for future com-
parative genomic studies (Ivens et al. 2005). The genome eluci-
dated the full structural architecture of Leishmania chromosomes,
which includes an unusual pattern of genes distributed in large
directional clusters. Subsequently, the genomes of L. braziliensis
and L. infantum were described—the latter is a member of the L.
donovani complex (Peacock et al. 2007). A detailed comparison of
these first three Leishmania genomes revealed a striking back-
ground of conservation at the gene-content level with almost
complete synteny. Moreover, in stark contrast to the major phe-
notypic differences caused by each species, less than 50 genes were
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differentially distributed, indicating that few genuinely species-
specific genesmay exist. This study, however, only honed in on the
presence or absence of orthologs. It did not include other classes of
diversity, such as structural polymorphisms within tandem arrays
or the generation of episomes; both of which have subsequently
been described as differing considerably between Leishmania lines
and as contributing substantial differences to gene expression
(Dujardin 2009; Leprohon et al. 2009a,b). Furthermore, the ge-
nome of L. donovani has thus far not been examined, despite it
being arguably the most important Leishmania species in terms of
public health, and being genetically distinct from L. infantum
(Lukes et al. 2007). Both in terms of mortality and morbidity, L.
donovani causes a major part of the leishmaniasis burden, in East
Africa and the Indian subcontinent (Rijal et al. 2010).
In the present study, we aimed to explore the intraspecies
genomic diversity of Leishmania in a clinical context. The first re-
gional program of visceral leishmaniasis elimination is targeting L.
donovani in Bangladesh, India, and Nepal (Mondal et al. 2009).
However, emerging drug resistance is compromising current ef-
forts. Understanding the L. donovani genome and its natural vari-
ation and genetic population structure in these regions is therefore
essential to underpin and enhance public health surveillance and
intervention strategies.
We focused specifically on L. donovani populations from the
Terai region of Nepal and the state of Bihar in India. These pop-
ulations constitute an ideal genomic model in which genetic var-
iation between samples should be reduced: Indeed, these parasites
are relatively homogeneous, likely as a result of a demographic
bottleneck in the 1960s, after DDT spraying campaigns (WHO
Expert Committee on the Control of the Leishmaniases 2010). In
addition, these isolates were the subjects of several recent studies,
providing a unique clinical, biological, and epidemiological back-
ground (Decuypere et al. 2005, 2008; Laurent et al. 2007; Alam
et al. 2009; Rijal et al. 2010; Vanaerschot et al. 2010). Importantly,
these parasites are highly variable in terms of susceptibility to an-
timonial drugs such as sodium stibogluconate (SSG; Rijal et al.
2007; Samant et al. 2007; Kumar et al. 2009).
Using a combination of 454 Life Sciences (Roche) and Illu-
mina sequencing technologies, we have generated a high-quality
and annotated draft genome for L. donovani.Wehave subsequently
used this reference genome as a framework to map natural varia-
tion data collected from deep resequencing of 16 further Nepalese
and Indian clinical lines. By discovering genome-wide single-
nucleotide polymorphisms (SNPs) and structural variation (SV),
we identified genes with differential patterns of diversity in anti-
monial resistant and susceptible samples. Both tests for adaptive
evolution across SNPs and assessments of copy-number variation
(CNV) highlighted subsets of protein-coding genes undergoing
adaptive evolution in the L. donovani population. As expected, we
saw a low level of SNP variation; but despite this, we report striking
structural polymorphisms that may result in locus-specific
changes to gene dosage. These include extensive chromosomal
CNVs as well as the generation of extrachromosomal circular
fragments.
Results
Generation of an annotated L. donovani reference genome
To investigate natural genetic variation in L. donovani, we selected
a single cloned line (BPK282/0cl4) fromNepal to use as a reference
and sequenced its genome by combining single and paired-end
reads from the 454 GS FLX Titanium platform (median 22-fold
coverage) with reads from Illumina Genome Analyzer (median 52-
fold coverage). The 454 data were assembled de novo, and the
Illumina data were used to iteratively correct errors in the con-
sensus sequence and close gaps (Supplemental Fig. S1). The initial
set of contigs—50% of which were 44.4 kb or greater (N50)—were
aligned, ordered, and oriented against the L. infantum JPCM5 ref-
erence genome (Peacock et al. 2007) to produce an assembledhigh-
quality draft L. donovani genome of length 32.4 Mb containing
2154 contigs and with a final N50 of 45.5 kb.
The reference genomewas annotated by identifying orthologous
genes within the L. infantum genome and transferring their an-
notation onto the L. donovani draft assembly. Of the 8395 genes
in the L. infantum genome (Peacock et al. 2007), 8252 were trans-
ferred to L. donovani using RATT (Otto et al. 2011). These included
33 genes assigned to 15 L. donovani contigs that could not be
uniquely associated with a chromosome; most of these genes oc-
curred in arrays with homology with multiple regions in the L.
donovani genome (Supplemental Tables S1, S2). A total of 143 genes
were not transferred from L. infantum because they occurred
within repetitive gene arrays, hadmultiple paralogs in L. infantum,
matched multiple regions, or were located in regions for which
local synteny was unresolved in L. donovani.
The L. donovani reference sequence was aligned to each of the
other previously described Leishmania genomes (L. infantum, L.
major, and L. braziliensis) (Peacock et al. 2007) and the recently
sequenced L. mexicana genome (Rogers et al. 2011). This high-
lighted substantial genetic differentiation at the species level
(Fig. 1A), with 156,274 nucleotide changes between the L.
infantum and L. donovani reference genomes: two of these
changes corrected in-frame stop codons in L. infantum-specific
pseudogenes with high identity to their L. donovani orthologs
(LdBPK_321870 and LdBPK_332420).
Genomic patterns of SNP diversity within L. donovani lines
We generated an average of 66-fold sequence coverage for each of
17 L. donovani lines derived from unique visceral leishmaniasis
patients, among whom there were different responses to antimo-
nial therapy (Supplemental Table S3). By mapping the sequencing
reads from these lines to the BPK282/0cl4 reference L. donovani
genome sequence, we called SNPs using a conservative approach
exploiting the read-depth coverage values across all lines to mini-
mize systematic errors ( Jiang et al. 2009; Lynch 2009). This ap-
proach identified SNPs at 3549 sites, of which 2933 were in non-
coding regions, 220 were synonymous mutations in coding
regions, and 396 caused changes at the protein sequence level. As
expected, there was evidence of extensive purifying selection at
genes: 17.4% of the SNP variation surveyed was in coding regions,
which account for 47.0% of the genome. Coding-sequence
mutations occurred in just 368 genes—263 had at least one pro-
tein-level polymorphism and 158 one or more silent changes. This
was confirmed by neutral allele frequency distributions for coding
and noncoding sites (Supplemental Fig. S2) and a higher rate of
synonymous variants segregating at intermediate allele frequen-
cies relative to nonsynonymous ones (Supplemental Fig. S3).
Despite a low level of genetic differentiation between the
lines, principal component analysis (PCA) of genome-wide nu-
cleotide variation (Fig. 1B), and a protein-level phylogenetic net-
work (Fig. 1C; Supplemental Fig. S4) both revealed significant
genetic differences in our population not detected by micro-
satellite profiling (Alam et al. 2009; Bhattarai et al. 2010). These
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distinct relationships resolved by genomic SNP data were closely
mirrored by phylogenetic signals inferred from large CNVs (Supple-
mental Fig. S5), and supported the possibility of multiple events of
emergence of SSG resistance (Laurent et al. 2007). Although geo-
graphic separation has played a significant role in genetic differenti-
ation between species (Lukes et al. 2007), no evidence for this was
found in the 17 lines, presumably due to the small geographic area
sampled and extensive local human migration (Rijal et al. 2010).
Similarly, little of the variability in SSGphenotype could be explained
directly by either genome-wide variation or geographic distance.
The sites most differentiated between the SSG-resistant and
SSG-susceptible lines across the genome, and so potentially in-
volved in the resistance phenotype, were identified using F-sta-
tistics (Wright 1951). We found a total of 41 SNPs with FST > 0.4,
and these most discriminating SNPs showed an excess of non-
synonymous mutations (Fisher’s Exact test P < 0.02) (Table 1). No
SNP completely discriminated between resistant from sensitive
lines, but 34 out of these 41were present solely and homozygously
in four related SSG-resistant lines (BHU568/0cl1, BHU573/0cl1,
BPK173/0cl3, and BPK275/0cl18; Supplemental Table S4). These
four lines likely share a recent common ancestor, so while our data
cannot resolve whether these variants were due to selective events
or population history, it is possible that some of these SNPsmay be
related to SSG resistance in this group of isolates.
Identifying recent selective events
this parasite population could be hin-
dered by complex population history and
modes of reproduction. L. donovani prop-
agation is largely clonal in regions of
endemic leishmaniasis, leading to high
levels of inbreeding (Gelanew et al. 2010;
Rougeron et al. 2010). Together with its
likely small effective population size
(Laurent et al. 2007), this means puri-
fying selection should be less efficient
at removing disadvantageous alleles,
obscuring signals of selective pressure
(Charlesworth 2009). Thus, the pattern
in our sample of low diversity (nucleo-
tide diversity, p = 68.6 per Mb) (Tajima
1983) and an excess of rare alleles (FS =
1.72) (Fu 1997) could be due to a pat-
tern of clonal reproduction as well as
purifying selection, which had a limited
power to remove mildly deleterious vari-
ants. Comparing the proportions of non-
synonymous and synonymous mutations
in our 17 lines and between the four other
Leishmania species (Fig. 2) showed that
a substantial proportion (0.55) of the pop-
ulation-level variationwasneutral or nearly
neutral, confirming that selection was rel-
atively weak within this cohort, though
stronger on high-frequency variants (Sup-
plemental Table S5; Supplemental Fig. S6).
Detecting ancient and recent adaptive
evolution in L. donovani
L. donovani has been a parasite of humans
for a long period of time, and so host-
specific selective processes are likely to
have shaped its genome (Stevens et al. 2001; Simpson et al. 2006).
Furthermore, genes are likely to show similar adaptive changes in
related species (Obbard et al. 2010). Consequently, by examing the
effects of long-term adaptation between species as well as recent
selective events in our population, novel insights into the func-
tional importance of genes in Leishmania can be revealed.
We used a series of complementary tests to examine variation
between five Leishmania genomes in the L. donovani lineage and
within our set of 17 L. donovani lines (Supplemental Fig. S7).
Twelve genes showed evidence of sustained positive selection
across the Leishmania genus, as inferred from a high ratio of non-
synonymous to synonymous subsitutions (v = dN/dS > 1) (Table 2;
Supplemental Fig. S8; Yang 2007). These include 10 not previously
identified in a similar test comparing L. infantum, L. major, and L.
braziliensis (Supplemental Tables S6, S7; Peacock et al. 2007). A L.
donovani lineage- and site-specific test of v values highlighted 11
individual sites in nine genes that have historically been under
directional selection in L. donovani (Supplemental Table S8; Yang
2007). These two analyses did not make use of the information
from our multiple L. donovani lines, so by comparing the relative
rates of coding sequence changes within the 17 lines to those be-
tween L. donovani and other Leishmania species, an additional 15
genes showing positive selectionwere identified with the direction
of selection test (Supplemental Table S9; Stoletzki and Eyre-Walker
Figure 1. The phylogenomic context of functional variation in clinical L. donovani lines. (A) A
neighbor-joining phylogenomic tree of Leishmania species. The relative similarity is shown (1% was
equivalent to 108,000 mutations). The first column indicates the fraction of the known genomes
orthologously aligned to L. donovani and the second is the number of SNPs identified (Table 2). (B)
Principle component analysis (PCA) of genomic SNP variation in the 17 L. donovani lines resistant (red)
and susceptible (blue) to SGG. The two most significant PCs distinguished three main groups, ac-
counting for 63.3% of the total variation. The PCA L. donovani line numbers correspond to those shown
in C, a median-joining phylogenetic network of genome-wide nonsynonymous sites variation (396
SNPs) for samples resistant (red) and susceptible (blue) to SSG from India (beginning with BHU) and
Nepal (BPK). The branch lengths displayed are proportional to the number of differences between lines.
The position of the ancestral node for L. infantum (black) was shortened: For comparison, the L.
donovani:L. infantum branch length was 138 times that between the most divergent L. donovani (1,
BHU568/0cl1; and 10, BPK035/0cl1).
Population genomics of Leishmania clinical strains
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2011). To identify genes with evidence of positive selection that
could not be aligned across all five genomes, pairwise comparisons
between L. donovani and each of the four other Leishmania species
identified 36 genes with consistently high DN/DS ratios (Supple-
mental Table S10). Finally, signatures of selection at genes were
explored using a genome-wide sliding-window approach for stan-
dardmeasures of diversity within the 17 lines: p, uW, (Supplemental
Fig. S9; Watterson 1975), and Tajima’s D (Supplemental Table S11;
Tajima 1989).
Many of the genes identified by these approaches encode
hypothetical proteins, but a number of results stand out as be-
ing explainable in terms of known gene
functions important to Leishmania bi-
ology. Molecular studies investigating an-
timonial resistance in L. donovani clinical
isolates have implicated modifications
to proteins topologically predisposed to
faster adaptation (Kim et al. 2007; Sackton
et al. 2007; Cui et al. 2009) such as surface
proteins (Samant et al. 2007) and trans-
porters (Mandal et al. 2010) in the SSG-
resistance phenotype. Here, we provide
evidence of ancient and recent adaptive
evolution both between Leishmania spe-
cies and in the L. donovani lineage at the
highly immunogenic amastin surface
glycoproteins (Wu et al. 2000; Stober et al.
2006; Jackson 2010).Diversity at these loci
should be advantageous within our set of
L. donovani lines, and, indeed, we detected
an excess of derived high-frequency SNPs
at one amastin locus, with half of the
12 protein-level SNPs in the 34D subfamily amastin gene
(LdBPK_341150) segregating at elevated frequencies (Supplemen-
tal Table S12).
Evidence of adaptive evolution was also consistently ob-
served in genes encoding surface proteins with roles in transport,
including some that have roles in SSG resistance. A high level
of diversity was found at an amino acid transporter locus
(LdBPK_310350, p = 0.9 per kb) that has been found to be down-
regulated in SSG-resistant L. donovani strains (Singh et al. 2010).
Several genes previously associated with drug resistance showed
signs of persistent positive selection in Leishmania, including
Figure 2. The neutrality of coding-site allele-frequency spectra. The allele-frequency spectrum for
SNPs at nonsynonymous (black line) and synonymous (dashed line) sites among the 17 samples for the
genome. Allele frequencies were computed using read-depth coverage values and were folded because
the selective process may act on both the ancestral alleles inferred from L. infantum as well as the derived
version with the L. donovani population. The ratio of nonsynonymous to synonymous SNPs approaches
one as the allele frequencies increase, suggesting that higher frequency variants are subject to stronger
purifying selection to remove deleterious alleles.
Table 1. Coding SNPs showing greatest differentiation between lines resistant and susceptible to SSG treatment
FST C
a Position Sb Rc Typed
Gene
product Site Gene ID
0.54 34 1046281e 0.81 0.00 N Conserved hypothetical protein H523Rf LdBPK_342390
0.44 2 36464 1.00 0.43 N Phosphatidylinositol 3-kinase R3452H LdBPK_020100
0.44 4 337729g 1.00 0.43 N Rhomboid-like serine protease A113V LdBPK_040850
0.44 7 383016 1.00 0.43 Syn Phosphoacetylglucosamine mutase 161V LdBPK_070930
0.44 12 128965 1.00 0.43 N Conserved hypothetical protein Y1230C LdBPK_120270
0.44 16 690776 1.00 0.43 N Conserved hypothetical protein Y1214C LdBPK_161760
0.44 19 412141 1.00 0.43 Syn 4-coumarate CoA ligase 395V LdBPK_190970
0.44 21 412303 1.00 0.43 Syn Hypothetical protein 251P LdBPK_211240
0.44 24 26882 1.00 0.43 N Ankyrin/TPR repeat protein A150V LdBPK_240130
0.44 25 702972g 1.00 0.43 N Conserved hypothetical protein A61E LdBPK_251890
0.44 31 553554g 1.00 0.43 Syn Conserved hypothetical proteinh 426T LdBPK_311340
0.44 31 555080 1.00 0.43 N Conserved hypothetical protein S268P LdBPK_311340
0.44 32 357021g 1.00 0.43 N Conserved hypothetical protein V125L LdBPK_320990
0.44 35 1773762g 1.00 0.43 N Conserved hypothetical protein A54T LdBPK_354470
0.44 36 886126g 1.00 0.43 Syn Conserved hypothetical protein 347T LdBPK_362330
0.42 33 1316522e 0.20 0.86 N Conserved hypothetical protein A390V LdBPK_333140
0.40 34 493541e 0.78 0.14 Syn Amastin-like surface protein 209A LdBPK_341150
SNPs were ranked by FST: This set of 17 all had FST > 0.4 (bootstrapping P < 0.02) and were in coding sequence; noncoding SNPs with FST > 0.4 are
in Supplemental Table S4.
aChromosome.
bFrequency of ancestral allele in SSG-sensitive set.
cFrequency in SSG-resistant set.
dN stands for nonsynonmous and Syn for synonymous.
eSites not among the 34 SNPs, where the derived allele was homozygous in SSG-resistant lines BHU568/0cl1, BHU573/0cl1, BPK173/0cl3, and BPK275/
0cl18, and was not in any other lines.
fPredicted to be tolerated by protein impact software.
gSNPs confirmed by allele-specific genotyping.
hContained two high-FST SNPs; locus had a positive direction of selection test value (Supplemental Table S9); predicted to have phosphatase 2C activity
(InterProScan IPR001932).
Downing et al.
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ATP-binding cassette elements (Castanys-Mun˜oz et al. 2008;
Leprohon et al. 2009b), histone genes (Singh et al. 2007), and the
nucleoside transporter 1 gene (LdBPK_151230) (Vasudevan et al.
2001).
The A2 protein plays a role in promastigote–amastigote dif-
ferentiation (Alcolea et al. 2010) and is expressed solely during
amastigote-stage host infection in L. donovani (Ghedin et al. 1998;
Zhang and Matlashewski 2001) but not L. major, and has been
associated with the differing disease tropisms between the two
species (Zhang et al. 2003). In contrast to the conserved A2 locus in
L. major (Garin et al. 2005), functional CNVs have been previously
observed in the L. donovani species complex, and we see significant
sequence diversity and structural variation at this region even be-
tween our related lines. Whereas 39 and 59 A2-related genes pos-
sessed nine high-frequency protein-level SNPs, genes on the rest of
that chromosome had only a total of four, suggesting a possible role
for variability at this locus inA2gene expression (Zhang et al. 2003).
Kinetoplastids use the thiol trypanothione and a redox in-
termediate, tryparedoxin, to defend against oxidative stress: genes
involved in this pathway are implicated in resistance to antimonial
drugs and in mediating host immune response. Tryparedoxin
peroxidase diminishes the inhibition of thiol redoxmetabolism by
antimonial drugs by reactive oxygen species reduction (Wyllie
et al. 2004, 2008; Ko¨nig and Fairlamb 2007; Mandal et al. 2007),
and is overexpressed in SSG-resistant clinical L. donovani (Wyllie
et al. 2010). The tryparedoxin locus itself may be associated with
both host immunogenicity and drug resistance in Leishmania
(Stober et al. 2005), and in particular, with the murine B-cell
response against L. infantum (Castro et al. 2004; Cabral et al.
2008). We discovered variation at three genes associated with
redox metabolism: the tryparedoxin peroxidase gene (LdBPK_
151140) showed signatures of selection on the L. donovani lineage
(Supplemental Table S9) and also had a pattern of balanced varia-
tion in the 17 lines. One tryparedoxin gene (LdBPK_ 291220) had
a protein-coding variant in a region of low diversity. In addition,
a cAMP-specific phosphodiesterase locus (LdBPK_151540) dis-
played evidence of adaptive evolution (Supplemental Table S9):
Reduced cAMP phosphodiesterase expression is associated with in-
creased resistance to antioxidant stress, possibly mediated by com-
ponents of thiol metabolism pathways in L. donovani (Bhattacharya
et al. 2009).
Whole-chromosome copy-number
variation
We used alignments of Illumina reads
against the reference L. donovani sequence
to assess chromosomal copynumber.Using
normalized read-depth (s, see Methods),
70.9% of chromosomes had a relative cov-
erage equivalent to one, but a significant
proportion of chromosomes deviated from
this value by discrete multiples, namely,
1.5- (24.3%), 2- (4.6%), and 2.5-fold (0.2%)
(Fig. 3). As validation, we quantified four
single-copy genes from chromosomes 17,
34, 36 (mean s = 1 in all lines), and 31
(mean s = 2) by qPCR across the 17 lines.
The amplification signal from genes on
chromosome 31 was 2.2-fold greater than
those on chromosomes 17, 34, and 36,
confirming the double copy number of
chromosome 31 (Mann-Whitney U, P <
0.001) (Mann andWhitney 1947).We thenexamined the read ratios
that support allele calls, to establish whether the baseline coverage
(s = 1) could be explained by monosomy (in which case, s = 1.5 and
s = 2.5would correspond tomixedpopulations) or disomy (inwhich
case, s = 1.5 and s = 2.5would correspond to trisomyand pentasomy,
respectively). Considering that the lines here analyzed were cloned,
monosomic chromosomes could be expected to be essentially ho-
mozygous at sequence level. This was not the case, as an average of
293 heterozygous SNPs were detected per strain on the nine chro-
mosomes showing s = 1. Accordingly, we concluded that the latter
chromosomes were disomic.
Fluorescent in situ hybridization (FISH) has been used to
characterize variable aneuploidy for seven chromosomes from
individual L. major parasites (Sterkers et al. 2010). Our sequencing
approach complements and extends the observation and pro-
vided a quantification of chromosomal copy number, for all
chromosomes, across a population of cells. Further analysis
revealed three main categories of chromosomes: nine chromo-
somes (17, 18, 19, 21, 25, 28, 30, 34, 36) with disomy in all lines;
chromosome 31 alone was tetrasomic in all 17 (Supplemental Fig.
S10), and the 26 remaining chromosomes showed variable pol-
ysomy values between lines (Fig. 3). As a consequence of this
polysomic diversity, the pattern of aneuploidy was unique for
each line. Although experimentally induced SSG-resistant L.
infantum strains showing aneuploidy have been associated with
the drug-resistance phenotype (Leprohon et al. 2009a), no clear
link was observed here: average s values of each individual
chromosome in the SSG-resistant and SSG-susceptible strains
were not significantly different (Supplemental Table S14). An
ongoing investigation into genome stability in BPK282/0cl4
revealed that aneuploidy was stable for at least 32 passages after
genome sequencing, thoughwe cannot exclude changes between
the time of isolation and the 30 passages prior to genome se-
quencing.
Structural variation in L. donovani
Within each chromosome, we used read-depth variation to iden-
tify loci with repeated genes (see Supplemental Table S15 for
BPK282/0cl4) and to assess copy-number variation (CNV) in the 17
strains. Evidence of large duplications and deletions were discovered
Table 2. Substitutions in Leishmania genomes compared twith the L. donovani genome
Species
L.
infantum
L.
major
L.
mexicana
L.
braziliensis
L.
donovani
Total substitutions 156,274 2,221,795 2,838,763 5,425,363 3549
Noncoding 108,956 1,492,716 1,887,762 3,056,798 2933
Coding 47,318 729,079 951,001 2,368,565 616
Nonsynonymous (DN) 25,289 365,080 476,459 1,227,707 pN = 396
Synonymous (DS) 22,645 364,551 475,158 1,140,857 pS = 220
Fraction of CDS SNPs 0.303 0.328 0.335 0.437 0.174
Divergence per kb 4.88 67.6 85.4 169.1 p = 68.6a
Genome size (bp) 32,055,853 32,855,403 33,254,784 32,091,314 32,444,998
Known orthologous sitesb bp 30,542,998 28,786,268 25,433,275 23,401,169 31,254,077
% 94.1 88.7 78.4 72.1 96.3
DN/DS 1.11 1.00 1.00 1.07 pN/pS = 1.80
FI = [DN/DS]/[pN/pS] 0.62 0.56 0.56 0.60 -
aNucleotide diversity per Mb.
bCompared with the L. donovani reference genome. DN is the number of nonsynonymous changes
between L. donovani and the given species, and DS the synonymous mutations. pN is the number of
nonsynonymous variants segregating in the 17 lines, and pS the synonymous ones. FI is the fixation
index. Intraspecific measures of variability for the 17 L. donovani lines are shown for comparison.
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(Supplemental Figs. S11–S14) as well as clustered single-copy genes
flanked by either short direct repeats, ribosomal mobile elements
(RIMES), or both. A subset of these protein-encoding genes, in ad-
dition to both the mini-exon and rDNA loci, significantly discrimi-
nated SSG-resistant from SSG-susceptible lines (Table 3).
Two tandem repeats were analyzed
in detail: rDNA transcription units
(chromosome 27) and mini-exon genes
(chromosome 2). Copy number per chro-
mosome ranged from six to 15 (mean
10.26 3.4) for the rDNA genes, and from
26 to 146 (88 6 28) for the mini-exon
genes, consistent with reported values
(Kebede et al. 1999; Inga et al. 1998).
Gene dosage per cell was estimated taking
into account the somy (copy number)
values of the respective chromosomes.
SSG-resistant parasites showed on aver-
age 44% fewer rDNA transcription units/
cell than the sensitive ones (MWU P =
0.046), and 77% more mini-exon genes
(MWU P = 0.004). Consequently, the ratio
of mini-exon to rDNA genes tended to be
higher in SSG-resistant lines (MWU P =
0.006). In addition, the SSG resistance lo-
cus (LdBPK_310950) was present in more
copies in SSG-resistant lines than in sus-
ceptible ones (24 vs. 20, MWU P = 0.046).
This reflects a pattern previously observed
in L. tarentolae, where the ortholog of
LdBPK_310950wasmorehighly expressed
in samples selected for SSG resistance
than in susceptible ones (Haimeur and
Ouellette 1998).
Genome segments flanked by re-
peats can form extrachromosomal circu-
lar episomes through homologous re-
combination between regions adjacent to the repeats (Leprohon
et al. 2009a). Here we observed two such regions: a 13.5-kb region
on chromosome 23 encompassing four genes (the H-locus, in-
cluding the ABC-thiol transporter MRPA gene) (Grondin et al.
1996), and a 15.8-kb segment on chromosome 36 containing four
Figure 3. Aneuploidy in natural populations of L. donovani. The heatmap shows the copy-number
status of the 36 chromosomes for the 17 lines as disomic (1, blue), trisomic (1.5, green), tetrasomic (2,
yellow), and pentasomic (2.5, ivory). The color key shows the normalized chromosome read-depth and
the distribution frequency.
Table 3. Major structural variants in L. donovani clinical lines differentiated SSG-resistant and SSG-susceptible groups
Chromosomal location Loci and gene products Gene ID
Median copy number
SSG-R SSG-S
2: 267,501–267,539 Mini-exons Nonea 288 156
8: 326,771–327,502 Amastin LdBPK_080760 15 9
10: 213,241–213,495 GP63, leishmanolysin metallo-peptidase Clan MA(M) Family M8 LdBPK_100510b 31 17
27: 1,016,848–1,021,502 28S RNA gamma, 28S RNA alpha, 5.8S RNA, 18S RNA Nonec 15 27
31: 354,449–359,110 SSG resistance protein LdBPK_310950d 24 20
36: 2,527,016–2,542,828 Tartrate-sensitive acid phosphatase LdBPK_366740e 31 23
Hypothetical protein LdBPK_366750f
MAPK homolog LdBPK_366760e
Histidine secretory acid phosphatase LdBPK_366770g
Regions with a differential copy-number between antimony-resistant (SSG-R) and antimony-sensitive (SSG-S) lines (MWU, P < 0.05; Supplemental Table
S14). Copy number of the respective loci or genes is shown as median per set. All are repetitive genes (GeneDB, www.genedb.org) except a candidate
episome region referred to here as the MAPK-locus (mitogen-activated protein kinase) was flanked by short repeats and/or ribosomal mobile elements
(RIMEs) containing a CNV encompassing five genes.
aInvolved in mRNA splicing.
bImplicated in parasite virulence (see Matlashewski 2001).
cFunctions in RNA translation.
dOverexpressed in antimonial-resistant L. tarentolae (Haimeur and Ouellette 1998).
eMitogen-activated protein kinase; associated with survival in macrophage (Saha et al. 1985).
fLinked to SSG-resistance (Singh et al. 2007).
gA gene encoding a ubiquitin fusion degradation protein (LdBPK_366780) is at the 39 end of the region.
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genes referred to here as the MAPK-locus (Fig. 4). We examined
the MAPK-locus to determine if the higher read-depth observed
was due to the presence of episomal DNA by using an assay combin-
ing alkaline lysis (to extract circular DNA) and PCR amplification
with primers situated at the edges of the chromosomal locus and
oriented externally (Fig. 4). With this design, PCR amplification
should be only possible when episomes are present, and assuming
that circularization would occur through homologous recom-
bination between the 822-bp region shared by two acid phos-
phatase genes located at both edges of the locus (LdBPK_366740
and LdBPK_366770), an amplicon of 1700 bp would be expected.
We observed amplicons of that size (Supplemental Fig. S15) and
the nucleotide-level sequence of the amplicon further verified this
assay. Gene dosage per cell showed that there were more copies of
the MAPK-locus in SSG-resistant than MAPK-sensitive lines (me-
dian 31 vs. 23, MWU P < 0.05) (Table 3). In contrast, no significant
differences were observed between SSG-resistant and SSG-sensitive
lines for the H-locus (median 8 vs. 7; Supplemental Table S14). The
ongoing genome stability study above revealed that the read-depth
of theMAPK-locus was stable from the initial sequencing time point
to passage number 32, though again, we cannot exclude that
changes might have occurred since the parasite was originally iso-
lated.
We analyzed the influence of somy variation on gene tran-
scription by comparing the coverage of cDNA and genomic DNA
reads mapped to the reference strain BPK282/0cl4: A poor correla-
tion was observed between the genomic and cDNA CDS coverage
read-depth (r2 = 0.29, t-test P < 7.753 104), but this increasedwhen
chromosome 31was excluded (r2 = 0.54, t-test P < 4.753 107)—the
latter tetrasomic chromosome showed a similar cDNA read-depth as
the disomic ones. Coverage for individual geneswas proportional to
the genomic copy number for repetitive genes (Supplemental
Table S15), though with some notable exceptions (e.g., alpha
tubulin or elongation factor 1-alpha loci), likely reflecting both
the increased stability of the corresponding mRNAs at the life
stage at which RNA was extracted, and also the complexity of
transcription on Leishmania.
Discussion
An ability to underpin large epidemiological studies with genome-
wide discovery of new variants is critically important. In this study,
we demonstrated the feasibility of using deep genome sequencing
to first produce a relevant reference genome, and second, to use it
to characterize natural variation in clinically isolated Leishmania
donovani parasites. Our study focused on the Indian subcontinent,
where L. donovani sequence diversity is low and a high sensitivity
to detect relevant variants is essential. Within this closely related
set of parasites from a single disease focus, whole-genome se-
quencing resolved the details of population structure not visible
using traditional multilocus typing methods (Alam et al. 2009).
We observed a low level of SNP variation between the 17
L. donovani lines sequenced here in comparison to other eukary-
otes and Leishmania species (Laurent et al. 2007). An excess of rare
nonsynonymous alleles were distributed across the genomes be-
yond levels predicted by interspecific comparisons, suggesting that
a recent population recovery after a sustained bottleneck may ex-
plain this pattern of diversity (Nielsen 2001; Hermisson 2009),
fitting the epidemiology of VL re-emergence and spreading after
DDT spraying campaigns. This pattern may mask signals of adap-
tive evolution (Elyashiv et al. 2010). Consequently, genotype and
phenotype changes in L. donovani should be examined in the
context of a dynamic population structure as well as selective
processes induced by drug treatment.
In contrast to the limited SNP variation among the 17 lines,
extensive variation in chromosomal copy number was discovered.
Aneuploidy is known to arise in Leishmania, but for only a small
number of chromosomes and under experimental conditions,
such as gene knockouts (Cruz et al. 1993) or induced in vitro drug
resistance (Ubeda et al. 2008; Leprohon et al. 2009a). Aneuploidy
has previously been observed in seven L. major chromosomes from
individual parasite cells of a laboratory strain using FISH (Sterkers
et al. 2010). In this studywe documented the phenomenon for the
first time on a genome-wide basis in clinical lines. Our results
demonstrated extensive variation in aneuploidy within the 17
lines, implying global differences in gene dosage; however, the
absence of a clear relationship with drug resistance contrasts with
earlier experimental work (Leprohon et al. 2009a). Although an-
euploidy was stable in culture, analysis of ploidy immediately after
parasite isolation, or if possible, directly in the patient might yet
reveal a correlation with a drug-resistance phenotype. Nonethe-
less, there was a remarkable disparity between the stable tetrasomy
and disomy observed for one and nine chromosomes, respectively,
and the highly variable somy of the 26 other chromosomes. Fur-
ther work is needed to understand the origin of aneuploidy; it
could be related to a chromosomal replication defect (Sterkers et al.
2010) or sexual recombination, followed by genome erosion as
proposed in Trypanosoma cruzi (Lewis et al. 2009).
Besides aneuploidy, two other features of Leishmania genome
plasticity contributed to gene-dosage differences on a finer scale.
The first was the expansion and contraction of genes in tandem
arrays. These are expressed through polycistronic transcription,
Figure 4. Copy-number variation spanning MAPK-locus on chromo-
some 36. Copy number per cell in L. donovani (red, SSG-R; blue, SSG-S)
was much higher for theMAPK locus than the chromosome 36 median for
L. donovani (black dashed line) and L. infantum (black). The amplified re-
gion is marked in gray and their white edges indicate the location of two
direct repeats. Genes within and adjacent to the amplified region are
given in black and light gray, respectively. The MAPK (mitogen-activated
protein kinase) gene is labeled as LMPK (LdBPK_366760). Recombination
events may occur through a highly homologous 220-bp region starting at
the start codon of the tartrate-sensitive acid phosphatase (LdBPK_366740)
and histidine secretory acid phosphatase (LdBPK_366770). LdBPK_366750
encodes a protein of unknown function. Two RIME (L. donovani ribosomal
mobile elements; light-blue) flank the duplicated region. Read-depth
values were computed using 1-kb sliding windows, and error bars are
shown for each kilobase.
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suggesting that the primary purpose of the arrayed structure is to
regulate gene dosage. As a result, changes in copy number could
contribute directly to variation in expression of antigen-related
genes (Victoir and Dujardin 2002). The second feature was an epi-
some that varied in copy number between our lines. Episomes have
previously beendetected after drug selection in vitro (Leprohon et al.
2009a), but for the first time, we document the amplification of the
episomal MAPK locus, containing a MAPK gene (LdBPK_366760)
likely to have a role in signal transduction (Wiese 2007) and an acid
phosphatase gene (LdBPK_366770) that could be expressed during
infection (Ellis et al. 1998). In one instance of induced drug re-
sistance, the phenotype and the corresponding episome were un-
stable in the absence of the drug pressure (Leprohon et al. 2009a).
However, resistance to antimonials is stable during in vitro main-
tenance (Laurent et al. 2007), suggesting that antimonial resistance
has a negligible fitness cost (Vanaerschot et al. 2010), which may
explain the stability of the MAPK episome in vitro. The biological
role of gene dosage caused by this assortment of SVs remains un-
explored. In trypanosomatids, gene expression is primarily regulated
at the post-transcriptional level rather than at initiation (McDonagh
et al. 2000), allowing up-regulation of expression by copy-number
amplification (Victoir and Dujardin 2002). We have shown in the
reference line that gene dosage strongly correlateswith transcription
levels, suggesting that theremay indeed be functional consequences
to this variability requiring exploration at proteome andmetabolome
levels.
We have also shown the contributing effects of both single-
nucleotide and structural polymorphisms to the population geno-
mics of these parasites. For instance, the SSG resistance locus
(LdBPK_310950) had a substantial difference in copy number be-
tween the SSG-resistant and SSG-susceptible lines, and had only
three distinct haplotypes despite the presence of six high-frequency
amino acid substitutions. Moreover, separate genome-wide phylo-
genetic analyses based on SNPs or CNVs both converged on strik-
ingly similar population structures. Thus, integrative approaches
that combine SNP and SV data to maximize the variation that is
included are likely to yield the greatest insights into the diversity of
parasite biology.
Distinct patterns of diversity were also detected by both SNP
and copy-number analyses in genes related to RNA stability and
translation. A trend of ancient adaptive evolutionwas perceptible at
six such genes, and extended regions of positive selectionwithin the
17 lines were observed at loci encoding components of ribosomes
and RNA-binding proteins (LdBPK_131120-1280, LdBPK_352230-
2370). These nucleotide-level signatures of selection were paral-
leled by significant SV at two loci essential for translation: the
rDNA and mini-exon genes. SSG-resistant lines had over twice as
many mini-exon genes per rDNA transcription unit compared
with SSG-sensitive ones. This intriguing disparity suggests that
systemic adaptations, which substantially and globally alter the
proteome, have a role in drug resistance—a concept that is sup-
ported by a previous metabolomic study, where 100 out of 340
detected metabolites differed in quantity between the drug re-
sistant and sensitive phenotypes (t’Kindt et al. 2010).
In this study we have attempted to link genome-wide varia-
tion of L. donovani strains to their differential responses to drug
exposure. We found evidence that drug resistance has multiple
origins even in closely related lines, mirroring results from other
parasites (Hawkins et al. 2008), and the associated differing geno-
mic signatures in our small sample of isolates is compatible with
a pleomorphic response. A full understanding of the emergence of
drug resistance even in this restricted regionwill require validation
in more strains. Even then, the genetic switches associated with
the phenotype diversity may be specific to this population, so a
broader sampling of genetic variation in L. donovaniwill be needed
to comprehensively describe population-level Leishmania variability
in a clinical context, particularly given that the substantial genetic
divergence between our referenceNepalese L. donovaniBPK282/0cl4
and the reference Spanish L. infantum JPCM5 strain suggests a sig-
nificant regional component to diversity in the L. donovani species
complex. Beyond deeper sampling, improved genome assemblies
will improve our ability to identify SVs, enhancing combined
analyses of SNPs and SVs, including identifying episomes and var-
iable chromosome copy number.
In terms of molecular adaptations of antimonial-resistant
parasites, our results support the concept of a systemic and pleo-
morphic response by L. donovani. On one hand, resistant and
sensitive parasites differ by a series of genetic features, some of
them being possibly related directly with an adaptation to anti-
monial pressure (like detoxifying enzymes or pumps), others being
connected with housekeeping adaptations (like the hits on trans-
lation machinery here evidenced). The concept of a systemic ad-
aptation is supported by metabolomic studies undertaken on
strains studied here (t’Kindt et al. 2010). It is likely that there is an
evolutionary cascade of adaptations, possibly to compensate the
cost of a previous one or to provide a more adequate frame for its
expression (for instance through adaptation of the translation
machinery). Further work at population and experimental levels is
required to elucidate this chain of events, but the power of full
genome sequencing and other "omics" is obviously unique to ad-
dress these questions in a systems biology approach. On the other
hand, the emergence of multiple origins of drug resistance in this
population together with different genomic signatures encoun-
tered among antimonial-resistant parasites is compatible with
a pleomorphic response of L. donovani. This is supported by pre-
vious studies targeting specific genes and pointing out different
patterns of overexpression in antimonial-resistant parasites (Adaui
et al. 2011).
This study lays the groundwork for more sensitive and pow-
erful approaches to collating genomic diversity, as well as com-
prehensively describing population-level Leishmania variability in
a clinical context. Within the region L. donovani, infection levels
are both endemic and epidemic. Changes in drug policy in the
Indian subcontinent (from SSG to miltefosine and probably to
combination treatment in the near future) are likely to result in
dynamic selective pressures thatmould the genome of this parasite
(MacLean et al. 2010). Continuous surveillance must be main-
tained to monitor the threat from the ongoing emergence of drug
resistance. The L. donovani reference genome provides a tool to
identify and analyze new variants as they emerge. With available
second-generation sequencing technologies, the approach of de-
veloping a reference and then studying the local population ge-
netics from within any study region, and for any parasite, is now
readily possible.
Methods
Sample collection
All 17 L. donovani isolates were obtained fromNepalese and Indian
patients with visceral leishmaniasis (Supplemental Table S3; Rijal
et al. 2010). Species identity of the 17 lines was confirmed by PCR–
RFLP analysis of cysteine proteinase b genes (Quispe-Tintaya et al.
2004), and 16 isolates were cloned by the microdrop method (Van
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Meirvenne et al. 1975). The 16 cloned lines and uncloned BPK085/
0 used in present study are referred to as lines. A line (BPK282/0cl4,
also known as BPK282/0 clone 4) was chosen as a biological refer-
ence for determination of the L. donovani genome by the Kaladrug-R
and Gemini consortia (www.leishrisk.net/kaladrug, www.leishrisk.
net/gemini) based on its characteristics of being drug-sensitive, easy
to manipulate in vitro, and a representative of the most frequent
microsatellite group in the Indian subcontinent (Alam et al. 2009).
In addition, it is sensitive to SSG and miltefosine, has good in-
fectivity both in animals in vivo and in macrophages in vitro, and
was isolated from a cured patient in the Nepalese endemic area with
a documented treatment outcome.
Sequencing and assembly of genome sequence data
A reference L. donovani genome sequence for isolate BPK282/0cl4
was produced using 1.29 million single-end and 3.58 million
paired-end 454 reads with an average length of 167 bp and a mean
insert size of 3 kb, corresponding to 815Mb of DNA (Supplemental
Methods). A total of 96% of the reads were assembled using
Newbler (Quinn et al. 2008) into an initial set of reference contigs
and scaffolds, with N50 values of 22.3 and 680 kb, respectively.
Three complementary genome assembly tools were used to
improve the accuracy of the BPK282/0cl4 contig sequences (Sup-
plemental Fig. S1). First, homopolymer errors induced by the 454
pyrosequencing were corrected by the Illumina reads, which had
a median depth of 52-fold for BPK282/0cl4: These shorter 76-base
reads had a more uniform genome-wide distribution, and thus
fewer homopolymer errors.Miscalled single bases and indels in the
454 contigs were corrected with iCORN (Iterative Correction of
Reference Nucleotides) (Otto et al. 2010), run for 14 iterations.
Second, the contigs were iteratively extended by locally assem-
bling Illumina data into gaps using IMAGE (Iteratively Mapping
andAssembly forGap Elimination) (Tsai et al. 2010) for 18 iterations.
In order to eliminate additional errors introduced by IMAGE,
iCORN was repeated for five further iterations. Third, the refined
contigs ordered and oriented against the closely related and largely
orthologous L. infauntum genome (Peacock et al. 2007) using AB-
ACAS (Algorithm Based Automatic Contiguation of Assembled
Sequences) (Assefa et al. 2009).
Quality control and read mapping of multiple lines
Excluding PCR duplicate reads, 41.0 Gb of sequence was generated
for the 17 lines using the Illumina platform: amean of 31.7million
reads per Illumina run (Supplemental Methods). On average, 27.3
million reads per lane (86.1%)were correctly paired andmapped to
chromosomes, and 1.7 million per lane (5.4%) to contigs not
assigned to chromosomes or to kDNA (Supplemental Tables S16,
S17).
Variability between Illumina sequencing runs made it neces-
sary to develop approaches to ensure that the data analyzed was of
high quality (Malhis and Jones 2010). Using the expected GC
content distribution from L. infantum (Peacock et al. 2007), the GC
distributions for the reads for each line were examined: The me-
dian was 0.62 for most data sets, but poor-quality ones had lower
values (Supplemental Fig. S16). Empirical examination of the se-
quence quality parameters and read-depth coverage with Samtools
v0.1.6 (Li et al. 2009) showed that the mode and median of base-
quality score (BQ ) and coverage could distinguish informative
from substandard sequencing data (Supplemental Fig. S17). The
latter had lower median coverage (<17 vs. 41+), coveragemode (<8
vs. 25+), median BQ (<58 vs. 72+), BQ mode (<34 vs. 65+). BQ was
the phred-style log-scaled adjusted probability that the given base
was incorrect.
Reads for each line were mapped to the reference chromo-
somes with SSAHA2 (Ning et al. 2001) using the Smith-Waterman
algorithm (Smith and Waterman 1981). All nonmapping and ar-
tificial duplicate reads were removed, as were sites with less than
threefold coverage, or with low BQ (<26) ormapping quality scores
(<31). Mapping quality reflected the probability of a given read
mapping uniquely to the genome sequence, such that reads de-
rived from DNA repeats with multiple high-orthology hits were
excluded.
Classifying kinetoplast DNA
Homology between all known minicircle (381) and maxicircle
(112) DNA sequences fromGenBank (www.ncbi.nlm.nih.gov) and
all contigs that could not be assigned to chromosomeswas assessed
usingMegaBLAST (Zhang et al. 2000) for pairs whose E value <0.01
and score >100 to remove short segmental partial hits. The L.
infantum and L. major genomes were included to identify contigs
that were chromosomal. This assigned 26 contigs (22.0 kbp) to
minicircles, two (19.0 kbp) to maxicircles; those that hit one or
more of the four categories (L. infantum, L. major, minicircle kDNA,
and maxicircle kDNA) were assigned as miscellaneous. The
amount of reads mapped to kDNA varied among the samples from
;10%–1% of the total, reflecting the difficulty in quantitatively
sequencing kDNA, particularly for minicircles due to their small
length.
Gene annotation verification
Annotating the L. donovani genome was aided by the shared ge-
nomic characteristics of Leishmania species with respect to codon
usage bias (Myler et al. 1999), its lack of cis-splicing and conserved
synteny (Peacock et al. 2007), as well as the relatively close genetic
relationship between L. infantum and L. donovani. L. infantum gene
models ( June 2010) were transferred to L. donovani based on se-
quence conservation and synteny with RATT (Rapid Annotation
Transfer Tool) (Otto et al. 2011). The resultant L. donovani gene
models were manually inspected and corrected where appropiate
using Artemis (Rutherford et al. 2000; Carver et al. 2008) and the
Artemis Comparison Tool (Carver et al. 2005). A scan for novel
open reading frames (ORFs) longer than 450 bp with distinct pat-
terns of codon usage and sequence similarity with other genes in
GenBank did not identify any new gene models.
SNP identification and validation
A series of SNP quality validation steps were implemented to ex-
clude sequencing errors andmapping artefacts. Candidate variable
sites and indels were initially identified with Samtools from loci
having a read-depth of <1000-fold and a maximum of three SNPs
in any given seven-base region. Perl scripts were used to select only
those candidate SNPs that met the following criteria: (1) the read
coverage for the variant base on the forward or reverse strand >3;
(2) a high SNP quality (>30); (3) genotypes were known in at least
half of the 34 genotypes; (4) at least one read-length (76 bp) distant
from contig gaps; and (5) normalized read-depth coverage was
within two standard deviations of the chromosome’s normalized
median value. SNP quality was the average BQ-weighted mapping
quality for all reads mapping to the site. If a candidate SNP was
heterozygous, the variant BQ was checked to ensure it was not
significantly worse than the reference genotype BQ.
In order to identify repetitive, arrayed, and paralogous DNA
segments, read-depth coverage was normalized for each chromo-
some by first measuring the coverage distribution at every position
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to which at least one readmapped (thus avoiding bias due to gaps).
After excluding sites whose coverage was more than one standard
deviation from the initial chromosome median, an optimized
chromosome median and standard deviation were determined for
interchromosomal comparisons of coverage, so that chromosomes
whose coverage was consistently higher or lower than other
chromosomes could be highlighted.
To counter elevated false-positive detection rates in repetitive
and paralogous regions, the average local uniqueness was de-
termined using a sliding window approach. Up- and downstream
from each site (on both strands), the minimum average point at
which a local region became unique (k bases) was evaluated. A total
of 97.9% of regions not containing gaps were unique for k < 30
(Supplemental Fig. S18), and for this threshold (k < 30) the relative
rates of singleton discovery in screened (30%) and unscreened
(45%) SNP sets were stable (Supplemental Fig. S19). All sites were
unique for k > 675, indicating that this was the maximum repeat
size in this version of the L. donovani genome.
In order to examine the validity of SNPs in both polymorphic
and paralogous regions, candidate SNPs were examined using PCR
of four amplicons (Supplemental Table S18) and with SNP geno-
typing. The SNP genotyping assayed 289 possible SNPs as repre-
sentatives of an initial set of 7642 variants in the 17 strains andwas
conducted in duplicate using mass spectrophotometry of allele-
specific amplified DNA on the Sequenom platform (Buetow et al.
2001).
Population-wide allele frequencies were estimated using read-
depth coverage values for each of the 17 lines pooled together, in
order to minimize epistatic biases associated with next generation
sequencing strategies ( Jiang et al. 2009; Lynch 2009). A scale of
SNP likelihood was used for interpreting the SNP genotyping re-
sults using the aligned L. infantum genome to determine the de-
rived allele for each of the 289 genotyped sites (Supplemental Fig.
S20). This approach was used to calculate the derived and folded
allele frequencies for the 3549 validated SNPs for the 17 lines.
Structural variation discovery
In devising the CNV detection criteria, we aimed to develop sen-
sitive methodology to identify real biological signals of CNVs in
the context of stochastic variability of read coverage and mis-
assembly (Lander and Waterman 1988). Median normalized read-
depth was measured at bases located within one standard de-
viation of the initial chromosomal median to remove outliers
caused by assembly gaps, spurious high-coverage regions, and
CNVs. Normalized read-depth per haploid genome (d) was defined
as a rawdepth (dr), divided by themediandepth of its chromosome
(dch): so that d = dr/dch.
To get chromosomal read-depths, the sequence data for each
sample was normalized using the median depth of 36 chromo-
somes of a line (dmch) to make comparisons between samples, and
the normalized median depths of disomic, trisomic, tetrasomic,
and pentasomic chromosomes become ;1.0, 1.5, 2.0, and 2.5,
respectively. So for a normalized chromosome read-depth or somy
value, s = (dch/dmch) a read-depth per cell (dpc) was defined as dpc =
2ds = 2d[dch//dmch] = 2[dr/dmch], thus reflecting differences in
somy number.
The detection of structural diversity was based on the as-
sumption that all genomic regions have equal probabilities of be-
ing sequenced by any read, such that coverage was a Poisson-dis-
tributed variable approaching a normal distribution as coverage
increases based on the central limit theory (Sebat 2007). Conse-
quently, SVs were detected with the read-depth coverage distri-
bution, and read-pair insert size distributions, microhomologies
(Hastings et al. 2009), and the densities of singleton reads whose
mate pair was unmapped were used to confirm or reject candidate
SVs.
In order to increase the specificity of SV analysis, candidates
were excluded if they met any of the following criteria: (1) their
length <1 kb or their normalized read-depth coverage was not
within two standard deviations of the normalized median for the
chromosome; (2) they were at chromosome ends; (3) they had
a pattern of uniformheterozygosity in the 17 lines; (4) theywere in
missing paralogous regions in comparison with L. infantum; or (5)
they were located in a region with low uniqueness (Supplemental
Fig. S18). In addition, SVs found in samples with high read-depth
variation (BPK043/0cl2, BPK067/0cl2, and BPK298/0cl8) were not
considered unless they were longer than 3 kb. L. donovani candi-
date regions were compared against L. infantum chromosomes
using BLAST (Altschul et al. 1990) and visualized in ACT (Artemis
Comparison Tool) (Carver et al. 2008). The depth coverage of L.
infantum reads mapped against BPK282/0cl4 also identified false
candidate SVs that were present in L. infantum. Small-scale SVs
were assessed using d to avoid calling SVs due to somy differences.
To determine genetic distances in the 17 lines to construct a
neighbor-joining tree, effective normalized copy numbers were es-
timated for each CNV from the normalized coverage levels. These
copy numbers were adjusted for effective normalized read-depths
(dn2) relative to theminimum (mind) andmaximum (maxd) values
in the set of samples, such that dn2 = (d–mind)/(maxd–mind) in
order to assess CNV variation in a quantitative manner. This ap-
proach precluded CNVs with extreme copy-number values from
skewing the analysis.
Experimental validation of the candidate episome
In order to prepare extrachromosomal circular DNA, an estimated
107 promastigotes of L. donovani line BPK275/0cl18 were selec-
tively denaturated by alkaline lysis (Sen et al. 1992). In order to
verify that extrachromosomal circular DNA contained amplicons
generated by circularization of theMAPK locus, externally oriented
primers homologous to the locus edges (TCTTGGCACGGCATC
AGCAG andCATGGCGCAGTGACCTTCAG) were used for 40 PCR
amplification cycles (Supplemental Methods). The nucletoide se-
quence of the amplified sequences was determined with an ABI
3730 automated sequencer (PerkinElmer).
Comparing the L. donovani genome to orthologous
Leishmania sequences
In order to compare orthologous sites between Leishmania species,
a series of tools were used to first identify conserved sequences;
second, expand the orthologous regions between genomes; and
third, align the orthologous pair (Nygaard et al. 2010). The initial
identification of conserved regions was conducted with Genscan
(Burge and Karlin 1997) to find genes to serve as syntenic anchors
for BLAT comparisons conducted in protein space (Kent 2002),
which were subsequently computed by Mercator (Dewey 2007).
Mercator iteratively expanded the local pairwise homologous re-
gions across the chromosomes to produce maps of syntenic re-
gions relative to reference L. donovani BPK282/0cl4 (L. infantum: 87
syntenic regions; L.major: 102; L. mexicana: 95; L. braziliensis: 237).
Alignment data produced by Mercator were combined with
a phylogenetic tree of the species-informed base-level alignments
of the orthologous regions (Mavid) (Bray and Pachter 2004). FSA
(Fast Statistical Alignment) (Bradley et al. 2009) estimated the lo-
cal level of homology of these synteny block alignments using
MUMmer v3.0 (Kurtz et al. 2004), and inserted gaps where ambi-
guities arose to ensure that any predictions of orthologymadewere
conservative.
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Substitutions at nonsynonymous, synonymous, and inter-
genic sites were determined, as were the derived alleles in the 17 L.
donovani lines and levels of divergence between species. To obtain
a comparative measure of variation between Leishmania species, a
neighbor-joining phylogenetic tree was constructed for all geno-
mic orthologous sites with Treepuzzle v5.2 (Schmidt et al. 2002).
Genomic scans for highly divergent regions between species in-
dicated faster rates of ancestral change—these can be symptomatic
of recent selective sweeps (Nielsen 2001).
The pairwise ratio dN/dS (v) was calculated for each CDS
alignment using the codeml implementation of the PAML 4.4
package (Yang 1997, 2007), where dN was the number of non-
synonymous mutations per nonsynonymous site, and dS the equiv-
alent for synonymous sites. If synonymous and nonsynonymous
mutations were neutral, it was expected that v = dN/dS = 1 (Yang
2002). Departures from this, where v > 1 (dN > dS), suggested that
nonsynonymous mutations could be advantageous and were
maintained under directional selection. If v < 1 (dN < dS), then
purifying selection may have eliminated deleterious nonsyn-
onymous variants (Yang 2002). One-ratio models estimated v
across the Leishmania lineage for each gene and this was compared
with models with v fixed as 1 using likelihood ratio tests (LRTs;
SupplementalMethods). In addition, LRTs between variable-v and
fixed-v branch-site models were conducted to find specific sites
under selection in the L. donovani lineage (Nielsen and Yang 1998).
These tests were complementary to branch-specific approaches
published for L. infantum, major, and braziliensis (Peacock et al.
2007).
Population diversity and structure analysis
Several complementary approaches were used to investigate
the genetic structure releveant to the clinical characteristics of
the lines. Median-joining networks of SNPs segregating at non-
synonymous and synonymous sites were constructed using Net-
work v4.2.0.1, excluding noninformative uniformly heterozygous
sites (Bandelt et al. 1999, www.fluxus-technology.com). Genetic
differentiation between SSG-resistant and SSG-susceptible groups
was assessed using FST (Wright 1951) based on the relative nucle-
otide diversity (p) (Tajima 1983): sites with FST > 0.4 (1.2%) had
gene-flow estimates 16 times lower than those with FST = 0.05
(Holsinger andWeir 2009). Possible associations between genomic
FST values, geographic great circle distance, and SSG phenotypes
for eachpair of lineswere also explored usingMantel-test approach
(Mantel 1967).
As a result of the low SNP-level diversity and the unique na-
ture of genome-wide haplotypes, allele frequency-based tests were
more instructive than haplotype-focused ones. To reflect the lack
of linkage information between genotypes, population metrics
were determined for each SNP as paired rather than individual
genotypes to avoid artifically constructing a balanced pattern of
diversity. These summary statistics includedWatterson’s uW,p, Fu’s
FS, and Tajima’s D (Tajima 1989); the latter reflected the stan-
dardized sample size-corrected difference between uW and p, and
should be minimal under neutrality. Sample sizes were corrected
for unknown genotypes at each SNP site. In order to distinguish
regions with differential diversity signals due to recent de-
mographic history, only extended regions were considered in
a sliding-window scan of intraspecific values of uW, p, and D.
The population-level spectrum of evolutionary change was
calculated for each gene as pN/pS, the ratio of nonsynonymous (pN)
to synonymous mutations (pS). Adjusting this ratio for LN (the
number of nonsynonymous sites) and LS (synonymous), estimated
using KaKs_Calculator (v1.2) (Zhang et al. 2006), gives the fraction
of neutral alleles segregating: f = [pN/pS]/[LN/LS], assuming little
temporal variation of selection (Smith and Eyre-Walker 2002).
Using pN/pS values for each gene and the ratio of fixed non-
synonymous (DN) and synonymous (DS) substitutions measured
between the orthologous alignments of the L. donovani and each of
the other Leishmania genomes, a series of McDonald–Kreitman-
based tests were implemented (McDonald and Kreitman 1991) for
a fixation index, FI = [DN/DS]/[pN/pS]. Because nonsynonymous
and synonymous sites were intercalated in coding sequences and
so closely share genealogical histories, the absolute numbers of
polymorphisms were examined rather than the rates alone, a via-
ble approach to investigating diversity in structurally variable
genes of indeterminant lengths (Nei et al. 2010). If FI > 1, it in-
dicated an elevated ancestral fixation rate of protein-level changes
in L. donovani (McDonald and Kreitman 1991). If FI < 1 with a high
pN/pS, this was likely to reflect relaxed selective constraint within
the population; or if DN/DS was low, ancestral purifying selection
(Eyre-Walker 2002). The expected contingency table values of DN,
DS, pN, and pS for each gene were determined and summed to
calculate an expected fixation index (eFI) (Gojobori et al. 2007).
The difference between FI and eFI, a = FI/eFI–1, was calculated to
evaluate the genomic scale of the abundance of adaptive and del-
eterious alleles segregating in the population (Axelsson and
Ellegren 2009).
To combat the challenge of searching for evidence of selective
processes in a data set with limited rates of intraspecific poly-
morphism, the direction of selection (DoS) test was conducted as
DoS = DN/[DN + DS]–pN/[pN + pS] (Stoletzki and Eyre-Walker 2011)
for genes with pN > 0: This also had the advantage of being less
prone to biases from purifying selection. In addition, genes likely
to possess a high fraction of adaptive variants were further iden-
tified by determining a = 1–1/FI (Smith and Eyre-Walker 2002).
Sites variable between species were determined as fixed if they
were conserved in the L. donovani population: As a consequence,
DN/DS values calculated for less-divergent species (such as L.
infantum)may bebiased by ancestral polymorphisms (Charlesworth
2009; Peterson andMasel 2009), and equally, saturation limitations
increase for highly divergent species. Moreover, using counts rather
than relative rates (DN vs. dN) of the numbers and types ofmutations
at structurally variable genes may be a viable compromise to omit-
ting such loci.
Data access
The annotated reference L. donovani genome for BPK282/0cl4
is available at the EMBL Nucleotide Sequence Database (http://
www.ebi.ac.uk/embl) (accession nos. FR799588–FR799623) and
fromGeneDB (http://www.genedb.org/Homepage/Ldonovani_
BPK282A1) and the strain-specific genotypes are browsable via
MapSeq (http://www.genedb.org/mapseq/Ldonovani).
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